ANGO Angiodynamics Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: ANGO

Price (delayed)

$5.87

Market cap

$235.12M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$4.78

Enterprise value

$156.67M

AngioDynamics, Inc. is a leading provider of innovative, minimally invasive medical devices used by professional healthcare providers for vascular access, peripheral vascular disease, and oncology. AngioDynamics' diverse product lines include ...

Highlights
The company's debt has shrunk by 100% YoY
The quick ratio has increased by 28% YoY and by 3.5% QoQ
Angiodynamics's equity has decreased by 45% from the previous quarter and by 45% YoY
ANGO's gross profit is down by 7% year-on-year and by 2.8% since the previous quarter
Sector: Healthcare
Industry: Medical Instruments & Supplies
Website: https://www.angiodynamics.com/
Peers: LMAT MMSI TFX ICUI

Key stats

What are the main financial stats of ANGO
Market
Shares outstanding
40.05M
Market cap
$235.12M
Enterprise value
$156.67M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
1.07
Price to sales (P/S)
0.73
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.48
Earnings
Revenue
$324.01M
EBIT
-$199.51M
EBITDA
-$169.01M
Free cash flow
$110.57M
Per share
EPS
-$4.78
Free cash flow per share
$2.75
Book value per share
$5.49
Revenue per share
$8.05
TBVPS
$6.05
Balance sheet
Total assets
$324.84M
Total liabilities
$106.14M
Debt
$0
Equity
$218.7M
Working capital
$111.03M
Liquidity
Debt to equity
0
Current ratio
2.29
Quick ratio
1.49
Net debt/EBITDA
0.46
Margins
EBITDA margin
-52.2%
Gross margin
50.2%
Net margin
-59.4%
Operating margin
-61.4%
Efficiency
Return on assets
-41.6%
Return on equity
-54%
Return on invested capital
-168.6%
Return on capital employed
-83.5%
Return on sales
-61.6%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

ANGO stock price

How has the Angiodynamics stock price performed over time
Intraday
-2.65%
1 week
-7.27%
1 month
9.51%
1 year
-33.07%
YTD
-25.13%
QTD
0%

Financial performance

How have Angiodynamics's revenue and profit performed over time
Revenue
$324.01M
Gross profit
$162.54M
Operating income
-$198.94M
Net income
-$192.37M
Gross margin
50.2%
Net margin
-59.4%
ANGO's gross profit is down by 7% year-on-year and by 2.8% since the previous quarter
The gross margin has decreased by 3.6% YoY
The revenue has declined by 3.2% year-on-year

Growth

What is Angiodynamics's growth rate over time

Valuation

What is Angiodynamics stock price valuation
P/E
N/A
P/B
1.07
P/S
0.73
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.48
Angiodynamics's equity has decreased by 45% from the previous quarter and by 45% YoY
The P/B is 34% more than the last 4 quarters average of 0.8 but 24% less than the 5-year quarterly average of 1.4
The P/S is 65% less than the 5-year quarterly average of 2.1 and 19% less than the last 4 quarters average of 0.9
The revenue has declined by 3.2% year-on-year

Efficiency

How efficient is Angiodynamics business performance

Dividends

What is ANGO's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ANGO.

Financial health

How did Angiodynamics financials performed over time
Angiodynamics's total assets has decreased by 40% YoY and by 35% QoQ
The quick ratio has increased by 28% YoY and by 3.5% QoQ
The company's debt is 100% lower than its equity
The debt to equity has plunged by 100% YoY
The company's debt has shrunk by 100% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.